We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NMRA market cap is 1.67B. The company's latest EPS is USD -1.4743 and P/E is -7.10.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -56.86M | -114M | -60.07M | -63.82M |
| Net Income | -53.03M | -108.73M | -53.72M | -58.7M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -237.32M | -135.87M | -252.1M |
| Net Income | -237.31M | -130.9M | -235.93M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||
| Total Assets | 544.75M | 496.2M | 450.21M | 404.47M |
| Total Liabilities | 32.06M | 27.12M | 25.67M | 23.21M |
| Total Equity | 512.69M | 469.08M | 424.54M | 381.26M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 429.3M | 426.23M | 496.2M |
| Total Liabilities | 24.66M | 29.4M | 27.12M |
| Total Equity | -325.22M | -446.85M | 469.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||
| Operating | -111.84M | -163.28M | -42.96M | -99.11M |
| Investing | 50.71M | 64.39M | -150M | -128.75M |
| Financing | 232.42M | 231.94M | 1.85M | 4.5M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Operating | -75.42M | -114.9M | -163.28M |
| Investing | -817k | -168.01M | 64.39M |
| Financing | 293.51M | 115.74M | 231.94M |
| Market Cap | 1.67B |
| Price to Earnings Ratio | -7.10 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.48 |
| Price to Book Ratio | 3.57 |
| Dividend Yield | - |
| Shares Outstanding | 160.03M |
| Average Volume (1 week) | 316.75k |
| Average Volume (1 Month) | 333.2k |
| 52 Week Change | -36.61% |
| 52 Week High | 21.00 |
| 52 Week Low | 8.33 |
| Spread (Intraday) | 7.81 (52.07%) |
| Company Name | Neumora Therapeutics Inc |
| Address |
1209 orange street new castle, delaware |
| Website | https://www.neumoratx.com. |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
